AFEYAN NOUBAR bought GENB

March 2, 2026 · Form 4 insider transaction

AFEYAN NOUBAR bought 2,777,752 shares of Generate Biomedicines, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,777,752
Price
N/A
Total value
N/A
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateMarch 2, 2026
Filing dateMarch 2, 2026
Shares owned after2,777,752
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Securities held by Flagship Pioneering Fund VI, L.P. ("Flagship Fund VI"). Flagship Pioneering Fund VI General Partner LLC ("Flagship Fund VI GP") is the general partner of Flagship Fund VI. Flagship Pioneering, LLC ("Flagship Pioneering") is the manager of Flagship Fund VI GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.; Securities held by Flagship Pioneering Special Opportunities Fund II, L.P. ("Flagship Opportunities Fund II"). Flagship Pioneering Special Opportunities Fund II General Partner LLC ("Flagship Opportunities Fund II GP") is the general partner of Flagship Opportunities Fund II. Flagship Pioneering is the manager of Flagship Opportunities Fund II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR
AFEYAN NOUBAR bought GENB: March 2, 2026 | Insider Trading Screener